1. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline Q1A(R2): Stability Testing of New Drug Substances and Products, Step 4, 6 February 2003, Available at: http://www.ich.org/.
2. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline Q1E: Evaluation for stability data, Step 4, 6 February 2003, Available at: http://www.ich.org/.
3. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline Q3A(R2): Impurities in New Drug Substances, Step 4, 25 October 2006, Available at: http://www.ich.org/.
4. International Conference on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline Q3B(R2): Impurities in New Drug Products, Step 4, 2 June 2006, Available at: http://www.ich.org/.
5. The role of degradant profiling in active pharmaceutical ingredients and drug products☆